Liquidators of biotech startup in talks over stake in drug firm

Liquidators of biotech startup in talks over stake in drug firm
Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)
Riley Kennedy
Liquidators of a collapsed animal-breeding startup are in talks about its stake in another drug development company.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise of $800,000 in 2016.However, it collapsed in June last year after failing to find enough commercial contracts for its pr...

More Primary Sector

Critical minerals miner plans 2026 NZX listing
Primary Sector

Critical minerals miner plans 2026 NZX listing

The company plans to raise $20m from retail investors in mid-2026.

Ruminant Biotech closes $17 million series A raise
Primary Sector

Ruminant Biotech closes $17 million series A raise

The agritech start-up plans its commercial launch in NZ and Australia next year.

Draft approval clears way for OceanaGold expansion
Primary Sector Exclusive

Draft approval clears way for OceanaGold expansion

The Waihi North Project is the first mine set to be approved under the fast-track law.

A cut to the milk price isn’t as bad as it sounds
Primary Sector

A cut to the milk price isn’t as bad as it sounds

A $9.50/kgMS price is still well ahead of breakeven.